# Tick-borne Encephalitis and Positive Borrelial Antibodies

> **NCT02463942** · NA · UNKNOWN · sponsor: **University Medical Centre Ljubljana** · enrollment: 100 (estimated)

## Conditions studied

- Tick-borne Encephalitis

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Symptomatic therapy
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT02463942
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463942, "Tick-borne Encephalitis and Positive Borrelial Antibodies". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02463942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*